Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Medical Access Program for Datopotamab Deruxtecan (Dato-DXd, DS-1062a)

NCT06279728 is registered in ClinicalTrials.gov with Daiichi Sankyo as lead sponsor.

NCT NCT06279728
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06279728 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Medical Access Program for Datopotamab Deruxtecan (Dato-DXd, DS-1062a)
Lead sponsor
Daiichi Sankyo
Phase
Expanded access
Overall status
Approved for marketing
Start date
Not reported
Completion date
Not reported
Enrollment
Not reported
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

egfrm advanced non-small cell lung cancer, egfrm metastatic non-small cell lung cancer